Novelcare provides software that connects community medical practices and trial sites by matching patient records to local clinical studies.
Novelcare has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in April 2023.
Novelcare's investors include Y Combinator, Palumni VC, Lombardstreet Ventures.
Novelcare is headquartered in New York, United States.
Novelcare provides software that connects community medical practices and trial sites by matching patient records to local clinical studies.
Novelcare is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Novelcare — Funding & Investors." VCBacked, April 14, 2023, https://www.vcbacked.co/company/novelcare. Accessed August 13, 2026.
VCBacked. (2023). Novelcare — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/novelcare
{{cite web |title=Novelcare — Funding & Investors |url=https://www.vcbacked.co/company/novelcare |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated